Works about CANDESARTAN

Results: 314

Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study.

Published in:

Liver International, 2012, v. 32, n. 6, p. 977, doi. 10.1111/j.1478-3231.2012.02774.x

By:

Kim, Moon Young;
Cho, Mee Yon;
Baik, Soon Koo;
Jeong, Phil Ho;
Suk, Ki Tae;
Jang, Yoon Ok;
Yea, Chang Jin;
Kim, Jae Woo;
Kim, Hyun Soo;
Kwon, Sang Ok;
Yoo, Byung Su;
Kim, Jang Young;
Eom, Min Seob;
Cha, Seung Hwan;
Chang, Sei Jin

Publication type:

Article

Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: formulation, characterization and in vitro drug release studies.

Published in:

AAPS Open, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s41120-017-0015-8

By:

Ali, Halah;
Hussein, Ahmed

Publication type:

Article

Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies.

Published in:

AAPS Open, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s41120-017-0016-7

By:

Ali, Halah;
Hussein, Ahmed

Publication type:

Article

Effect of Extracellular Matrix Stiffness on Candesartan Efficacy in Anti-Fibrosis and Antioxidation.

Published in:

Antioxidants, 2023, v. 12, n. 3, p. 679, doi. 10.3390/antiox12030679

By:

Zhu, Tong;
Song, Jingjing;
Gao, Bin;
Zhang, Junjie;
Li, Yabei;
Ye, Zhaoyang;
Zhao, Yuxiang;
Guo, Xiaogang;
Xu, Feng;
Li, Fei

Publication type:

Article

THE SIMULTANEOUS SPECTRAL DETERMINATION OF CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE IN TABLETS USING THE TRIVARIATE CLASSICAL LEAST SQUARES METHOD.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2024, v. 48, n. 3, p. 803, doi. 10.33483/jfpau.1441955

By:

ÜÇER, Asiye;
ÜSTÜNDAĞ, Özgür;
SAKLI, Uğur;
DİNÇ, Erdal

Publication type:

Article

VALIDATION STUDY OF A SPECTROPHOTOMETRIC BINARY MICTURE ANALYSIS.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2021, v. 45, n. 3, p. 545, doi. 10.33483/jfpau.989819

By:

ÜSTÜNDAĞ, Özgür;
DİNÇ, Erdal

Publication type:

Article

Is Ace Inhibitor/Angiotensin-Receptor Blocker Associated with Acute Kidney Injury Post-Coronary Artery Bypass Grafting in a Mixed Ethnicity Population in a Community-Based Hospital in Hawai'i?

Published in:

Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 9, p. 44

By:

Toledo, Ma Clarisse;
Tantisattamo, Ekamol;
Shigaki, Dorothy;
Ng, Roland C. K.

Publication type:

Article

Safety of Candesartan, Amlodipine, and Atorvastatin in Combination: Interaction Study in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 190, doi. 10.1002/cpdd.787

By:

Gundlach, Kristina;
Wolf, Katharina;
Salem, Isam;
Randerath, Olaf;
Seiler, Dan

Publication type:

Article

Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 492, doi. 10.1002/cpdd.321

By:

Patel, Rajesh;
Palmer, Jonathan L.;
Joshi, Shashidhar;
Di Ció Gimena, Alejandro;
Esquivel, Florencia

Publication type:

Article

Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2009, v. 34, n. 6, p. 683, doi. 10.1111/j.1365-2710.2009.01053.x

By:

Miura, M.;
Satoh, S.;
Kagaya, H.;
Saito, M.;
Inoue, T.;
Ohkubo, T.;
Habuchi, T.;
Suzuki, T.

Publication type:

Article

Adverse events of hepatic anti-fibrotic agents in phase 3 and above clinical trials: a descriptive analysis of the WHO-VigiAccess database.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1534628

By:

Liu, Yuwei;
Zhao, Xu;
Wang, Xinrui;
Zhou, Qiang

Publication type:

Article

A tale of two halves.

Published in:

Prescriber, 2014, v. 25, n. 17, p. 40, doi. 10.1002/psb.1240

By:

Thompson, Angus

Publication type:

Article

Angiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine-induced inflammatory response and cellular activation of BV2 cells via the PPARγ/AMPK signaling pathway.

Published in:

Molecular Medicine Reports, 2022, v. 26, n. 4, p. N.PAG, doi. 10.3892/mmr.2022.12834

By:

Zhao, Wenxin;
Shen, Feiyan;
Yao, Jixiang;
Su, Shanshan;
Zhao, Zhongmin

Publication type:

Article

Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF-κB signaling pathway.

Published in:

Molecular Medicine Reports, 2018, v. 18, n. 1, p. 705, doi. 10.3892/mmr.2018.9070

By:

Zhao, Xudong;
Wang, Xietong

Publication type:

Article

Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 6, p. 8193, doi. 10.3892/mmr.2015.4432

By:

XUEFENG LIN;
MIN WU;
BO LIU;
JUNKUI WANG;
GONGCHANG GUAN;
AIQUN MA;
YONG ZHANG

Publication type:

Article

An Internal Standard High-Performance Liquid Chromatography Method for Simultaneous Quantification of Candesartan and Hydrochlorothiazide in Combined Formulations.

Published in:

Oriental Journal of Chemistry, 2021, v. 37, n. 5, p. 1077, doi. 10.13005/ojc/370509

By:

ALGETHAMI, FAISAL K.

Publication type:

Article

Predictors of candesartan's effect on vascular reactivity in patients with coronary artery disease.

Published in:

Cardiovascular Therapeutics, 2017, v. 35, n. 5, p. n/a, doi. 10.1111/1755-5922.12291

By:

Lee, So‐Ryoung;
Chae, In‐Ho;
Kim, Hack‐Lyoung;
Kang, Do‐Yoon;
Kim, Sang‐Hyun;
Kim, Hyo‐Soo

Publication type:

Article

Role of NF-κβ and Oxidative Pathways in Atherosclerosis: Cross-Talk Between Dyslipidemia and Candesartan.

Published in:

Cardiovascular Therapeutics, 2013, v. 31, n. 6, p. 381, doi. 10.1111/1755-5922.12033

By:

Hadi, Najah R.;
Yousif, Nasser Ghaly;
Abdulzahra, Mohammed S.;
Mohammad, Bassim I.;
al‐amran, Fadhil G.;
Majeed, Murooge L.;
Yousif, Maitham G.

Publication type:

Article

Cramming on potato starch as a novel superdisintegrant for depiction and characterization of candesartan cilexetil fast dissolving tablet.

Published in:

Thai Journal of Pharmaceutical Sciences, 2021, v. 45, n. 2, p. 137

By:

Vemuri, Venkata Deepthi;
Nalla, Swathi;
Gowri, Gollu;
Mathala, Nalini

Publication type:

Article

Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways.

Published in:

Frontiers in Neuroscience, 2021, v. 15, p. N.PAG, doi. 10.3389/fnins.2021.636259

By:

Attilio, Peter J.;
Snapper, Dustin M.;
Rusnak, Milan;
Isaac, Akira;
Soltis, Anthony R.;
Wilkerson, Matthew D.;
Dalgard, Clifton L.;
Symes, Aviva J.

Publication type:

Article

Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4.

Published in:

Frontiers in Neuroscience, 2021, v. 14, p. N.PAG, doi. 10.3389/fnins.2021.628403

By:

Scheinman, Sarah B.;
Zaldua, Steve;
Dada, Adedoyin;
Krochmaliuk, Kateryna;
Dye, Katherine;
Marottoli, Felecia M.;
Thatcher, Gregory R. J.;
Tai, Leon M.

Publication type:

Article

Exploring Cosolvency in Analytical Method Development and Validation of Poorly Aqueous Soluble Candesartan Cilexetil in Bulk and Dosage Forms.

Published in:

Indian Journal of Pharmaceutical Sciences, 2024, v. 86, n. 2, p. 660, doi. 10.36468/pharmaceutical-sciences.1320

By:

YADAV, P. S.;
HAJARE, A. A.;
DHOLE, R. S.;
DHARANGUTIKAR, S. V.

Publication type:

Article

Determination of Acetaldehyde Content in Candesartan Cilexetil by HPLC.

Published in:

Indian Journal of Pharmaceutical Sciences, 2018, v. 80, n. 4, p. 744, doi. 10.4172/pharmaceutical-sciences.1000415

By:

KUMAR, S. S.;
SRIVASTAVA, R. K.

Publication type:

Article

Angiotensin II antagonists - an assessment of their acute toxicity.

Published in:

Clinical Toxicology (15563650), 2013, v. 51, n. 5, p. 429, doi. 10.3109/15563650.2013.800875

By:

Prasa, Dagmar;
Hoffmann-Walbeck, Petra;
Barth, Susanne;
Stedtler, Uwe;
Ceschi, Alessandro;
Färber, Elke;
Genser, Dieter;
Seidel, Carola;
Deters, Michael

Publication type:

Article

Top 10 drugs 2023-24.

Published in:: Australian Prescriber, 2024, v. 47, n. 6, p. 194, doi. 10.18773/austprescr.2024.048
Publication type:: Article

Top 10 drugs 2022-23.

Published in:: Australian Prescriber, 2023, v. 46, n. 4, p. 93, doi. 10.18773/austprescr.2023.030
Publication type:: Article

Top 10 drugs 2021-22.

Published in:: Australian Prescriber, 2023, v. 46, n. 4, p. 92, doi. 10.18773/austprescr.2023.029
Publication type:: Article

Top 10 drugs 2020-21.

Published in:: Australian Prescriber, 2021, v. 44, n. 6, p. 205, doi. 10.18773/austprescr.2021.062
Publication type:: Article

Top 10 drugs 2019-20.

Published in:: Australian Prescriber, 2020, v. 43, n. 6, p. 209, doi. 10.18773/austprescr.2020.075
Publication type:: Article

Medicines Safety Update.

Published in:: Australian Prescriber, 2012, v. 35, n. 3, p. 98
Publication type:: Article

Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment.

Published in:

Environmental Science & Pollution Research, 2014, v. 21, n. 18, p. 10830, doi. 10.1007/s11356-014-3060-z

By:

Bayer, Anne;
Asner, Robert;
Schüssler, Walter;
Kopf, Willi;
Weiß, Klaus;
Sengl, Manfred;
Letzel, Marion

Publication type:

Article

Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspective.

Published in:

2001

By:

Yuval, Rita;
Uziel, Klari;
Gordon, Nomi;
Merdler, Amnon;
Khader, Nader;
Karkabi, Basheer;
Flugelman, Moshe Y.;
Halon, David A.;
Lewis, Basil S.;
Yuval, R;
Uziel, K;
Gordon, N;
Merdler, A;
Khader, N;
Karkabi, B;
Flugelman, M Y;
Halon, D A;
Lewis, B S

Publication type:

journal article

Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.

Published in:

Molecular & Cellular Biochemistry, 2013, v. 376, n. 1/2, p. 175, doi. 10.1007/s11010-013-1565-2

By:

Palaniyappan, Ariv;
Uwiera, Richard;
Idikio, Halliday;
Menon, Vijay;
Jugdutt, Catherine;
Jugdutt, Bodh

Publication type:

Article

Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction.

Published in:

Molecular & Cellular Biochemistry, 2009, v. 321, n. 1/2, p. 9

By:

Arivazhagan Palaniyappan;
Richard Uwiera;
Halliday Idikio

Publication type:

Article

Medical options to fight mortality in end-stage renal disease: a review of the literature.

Published in:

Nephrology Dialysis Transplantation, 2012, v. 27, n. 12, p. 4298, doi. 10.1093/ndt/gfs400

By:

Kramann, Rafael;
Floege, Jürgen;
Ketteler, Markus;
Marx, Nikolaus;
Brandenburg, Vincent M.

Publication type:

Article

Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.

Published in:

Nephrology Dialysis Transplantation, 2010, v. 25, n. 3, p. 842, doi. 10.1093/ndt/gfp547

By:

Frimodt-Møller, Marie;
Høj Nielsen, Arne;
Strandgaard, Svend;
Kamper, Anne-Lise

Publication type:

Article

Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.

Published in:

Nephrology Dialysis Transplantation, 2010, v. 25, n. 3, p. 967, doi. 10.1093/ndt/gfp581

By:

Philipp, Thomas;
Martinez, Franck;
Geiger, Helmut;
Moulin, Bruno;
Mourad, Georges;
Schmieder, Roland;
Lièvre, Michel;
Heemann, Uwe;
Legendre, Christophe

Publication type:

Article

Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.

Published in:

Nephrology Dialysis Transplantation, 2010, v. 25, n. 2, p. 389, doi. 10.1093/ndt/gfp472

By:

Sungjin Chung;
Cheol Whee Park;
Seok Joon Shin;
Ji Hee Lim;
Hyun Wha Chung;
Dong-Ye Youn;
Hyung Wook Kim;
Byung Soo Kim;
Jeong-Hwa Lee;
Gheun-Ho Kim;
Yoon Sik Chang

Publication type:

Article

The Solubility of Ethyl Candesartan in Mono Solvents and Investigation of Intermolecular Interactions.

Published in:

Liquids (2673-8015), 2022, v. 2, n. 4, p. 404, doi. 10.3390/liquids2040023

By:

Du, Cunbin

Publication type:

Article

Simple, Accurate and Multianalyte Determination of Thirteen Active Pharmaceutical Ingredients in Polypills by HPLC-DAD.

Published in:

Chemosensors, 2023, v. 11, n. 1, p. 25, doi. 10.3390/chemosensors11010025

By:

Żuromska-Witek, Barbara;
Stolarczyk, Mariusz;
Szlósarczyk, Marek;
Kielar, Szymon;
Hubicka, Urszula

Publication type:

Article

ANALYSIS OF FUNCTIONAL CHANGES UNDER USING OF CANDESARTAN CILEXETIL WITH RESVERATROL IN ANIMA.

Published in:

Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2021, v. 84, n. 1, p. 24, doi. 10.17721/1728_2748.2021.84.24–27

By:

Beliayeva, A.;
Garmanchuk, L.

Publication type:

Article

CHANGING IN THE NUMBER OF CD117+ STEM CELLS, CYTOGENETIC AND CYTOKINETIC PARAMETERS UNDER THE USING OF CANDESARTAN, CANDESARTAN CILEXETIL AND RESVERATROL IN VITRO.

Published in:

Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2019, v. 79, n. 3, p. 54, doi. 10.17721/1728_2748.2019.79.54-57

By:

Beliayeva, А.;
Garmanchuk, L.

Publication type:

Article

Erratum in 'Antioxidant Activity-Mediated Neuroprotective Effects of an Antagonist of AT1 Receptors, Candesartan, Against Cerebral Ischemia and Edema in Rats,'.

Published in:

2014

By:

Panahpour, H.

Publication type:

Erratum

Antioxidant Activity-Mediated Neuroprotective Effects of an Antagonist of AT1 Receptors, Candesartan, against Cerebral Ischemia and Edema in Rats.

Published in:

Neurophysiology, 2013, v. 45, n. 5/6, p. 441, doi. 10.1007/s11062-013-9391-4

By:

Panahpour, H.;
Bohlooli, Sh.;
Motavallibashi, S.

Publication type:

Article

Tumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapy.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 14, n. 3, p. 2162, doi. 10.3892/etm.2017.4777

By:

TIANYING ZHENG;
AIJUN WANG;
DONGYAN HU;
YONGGANG WANG

Publication type:

Article

Candesartan cilexetil prevents diet-induced insulin resistance via peroxisome proliferator-activated receptor-γ activation in an obese rat model.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 12, n. 1, p. 272, doi. 10.3892/etm.2016.3297

By:

WEN-HUA YAN;
CHANG-YU PAN;
JING-TAO DOU;
JUN-HUA MENG;
BAO-AN WANG;
YI-MING MU

Publication type:

Article

Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74003-5

By:

Soh, Moon-Seung;
Won, Kyung-heon;
Kim, Jae-Joong;
Lee, Sung Yun;
Hyon, Min Su;
Youn, Ho-Joong;
Rha, Seung-Woon;
Kim, Doo-Il;
Ahn, Youngkeun;
Kim, Byung Jin;
Choi, Dong-Ju;
Park, Jong-Seon;
Kim, Dae-Kyung;
Park, Woo-Jung;
Lim, Hong-Seok;
Tahk, Seung-Jea

Publication type:

Article

Practitioner's Trial on the Efficacy of Antihypertensive Treatment in Elderly Patients with Hypertension II (PATE-Hypertension II study) in Japan.

Published in:

Geriatrics & Gerontology International, 2011, v. 11, n. 4, p. 414, doi. 10.1111/j.1447-0594.2011.00690.x

By:

Ogihara, Toshio;
Matsuoka, Hiroaki;
Rakugi, Hiromi

Publication type:

Article

A Study of effect of Perindopril and Candesartan on Pain Perception in Albino Rats.

Published in:

Indian Journal of Public Health Research & Development, 2014, v. 5, n. 3, p. 40, doi. 10.5958/0976-5506.2014.00270.8

By:

Purushotham, Naidu R.;
Rekha, M. S.

Publication type:

Article

Oral Gels as an Alternative to Liquid Pediatric Suspensions Compounded from Commercial Tablets.

Published in:

Pharmaceutics, 2024, v. 16, n. 9, p. 1229, doi. 10.3390/pharmaceutics16091229

By:

Trofimiuk, Monika;
Sznitowska, Małgorzata;
Winnicka, Katarzyna

Publication type:

Article